The potential for vaccine development against rheumatic fever.
Medina
Eva
E
Department of Microbial Pathogenesis and Vaccine Research, GBF-National Research Centre for Biotechnology, Braunschweig, Germany.
Chhatwal
Gursharan S
GS
D000208:Acute Disease; D001315:Australia / Q000453:epidemiology; D006801:Humans; D016233:Immunotherapy, Active / Q000639:trends; D015994:Incidence; D012213:Rheumatic Fever / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D012214:Rheumatic Heart Disease / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control*; D013290:Streptococcal Infections / Q000188:drug therapy / Q000276:immunology; D013297:Streptococcus pyogenes / Q000187:drug effects / Q000276:immunology; D006113:United Kingdom / Q000453:epidemiology; D014481:United States / Q000453:epidemiology